一个抗eCIRP策略用于死性肠球炎
Colleen P Nofi1,2,3, Jose M Prince1,3, Mariana R Brewer4
1Center for Immunology and Inflammation, the Feinstein Institutes for Medical Research, 350 Community Dr., Manhasset, NY, 11030, USA.
Molecular medicine (Cambridge, Mass.)
|September 20, 2024
概括
细胞外冷诱导性RNA结合蛋白 (eCIRP) 恶化了死角性肠球炎 (NEC). 用MOP3来准eCIRP显著改善了NEC的小鼠模型中的生存率并减少了损伤.
科学领域:
- 新生儿研究新生儿研究
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
背景情况:
- 死性肠球炎 (NEC) 是一种严重的新生儿胃肠道疾病,死亡率高.
- 细胞外冷诱导性RNA结合蛋白 (eCIRP) 与炎症和组织损伤有关.
- 目前尚不清楚eCIRP在NEC病原发生中的作用.
研究的目的:
- 调查eCIRP在NEC中的作用.
- 为了评估一个eCIRP-scavenging的治疗潜力,MOP3,在NEC.
主要方法:
- 从新生儿的便样本中测量CIRP水平,有或没有NEC.
- 利用了NEC的小鼠模型,其中包括缺氧,高热量输液和LPS.
- 评估了NEC严重程度,肠道和肺部损伤,屏障功能障碍以及野生类型和CIRP淘汰赛小鼠的存活率,有或没有MOP3治疗.
主要成果:
- 在NEC新生儿中发现了高CIRP水平.
- CIRP淘汰赛小鼠对NEC有显著的保护,显示受伤和炎症减少,存活率为100%.
- MOP3治疗将NEC存活率提高到80%,并减轻了器官损伤和炎症.
结论:
- 在CIRP缺乏的小鼠中,eCIRP会加剧NEC的病原性,这是CIRP缺乏小鼠的保护所证明的.
- MOP3,一种针对eCIRP的新型治疗方法,在治疗NEC时显示出有前途.
- eCIRP代表了人类NEC的相关治疗目标.
相关概念视频
Peptic Ulcer Disease V: Surgical Management and Nursing Care
238
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
238
Inflammatory Bowel Disease V: Surgical Management
128
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
128
Acute Respiratory Failure-V
124
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
124


